0001209191-21-040944.txt : 20210616
0001209191-21-040944.hdr.sgml : 20210616
20210616170015
ACCESSION NUMBER: 0001209191-21-040944
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Winslow Garrett
CENTRAL INDEX KEY: 0001803773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39655
FILM NUMBER: 211022164
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: C/O SPRING BANK PHARMACEUTICALS, INC.
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galecto, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 45-70-70-52-10
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-15
0
0001800315
Galecto, Inc.
GLTO
0001803773
Winslow Garrett
C/O GALECTO, INC.
OLE MAALOES VEJ 3
COPENHAGEN N
G7
DK-2200
DENMARK
0
1
0
0
General Counsel
Stock Option (right to buy)
5.61
2021-06-15
4
A
0
120000
0.00
A
2031-06-14
Common Stock
120000
120000
D
25% of the shares subject to such option will vest and become exercisable on May 2, 2022 and the remainder of the shares will vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Garrett Winslow
2021-06-16